Literature DB >> 27686406

Inhibitory mechanism of peptides with a repeating hydrophobic and hydrophilic residue pattern on interleukin-10.

Guoying Ni1,2, Yuejian Wang3, Scott Cummins1, Shelley Walton4, Kate Mounsey4, Xiaosong Liu3,4, Ming Q Wei2, Tianfang Wang1.   

Abstract

Interleukin 10 (IL-10) is a cytokine that is able to downregulate inflammation. Its overexpression is directly associated with the difficulty in the clearance of chronic viral infections, such as chronic hepatitis B, hepatitis C and HIV infection, and infection-related cancer. IL-10 signaling blockade has been proposed as a promising way of clearing chronic viral infection and preventing tumor growth in animal models. Recently, we have reported that peptides with a helical repeating pattern of hydrophobic and hydrophilic residues are able to inhibit IL-10 significantly both in vitro and in vivo. 1 In this work, we seek to further study the inhibiting mechanism of these peptides using sequence-modified peptides. As evidenced by both experimental and molecular dynamics simulation in concert the N-terminal hydrophobic peptide constructed with repeating hydrophobic and hydrophilic pattern of residues is more likely to inhibit IL10. In addition, the sequence length and the ability of protonation are also important for inhibition activity.

Entities:  

Keywords:  ELISA; circular dichroism spectroscopy; interleukin-10 inhibiting peptide; interleukin-10 receptor; molecular dynamic simulation; surface plasmon resonance spectroscopy

Mesh:

Substances:

Year:  2016        PMID: 27686406      PMCID: PMC5360125          DOI: 10.1080/21645515.2016.1238537

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  63 in total

1.  The enthalpy of the alanine peptide helix measured by isothermal titration calorimetry using metal-binding to induce helix formation.

Authors:  Maria M Lopez; Der-Hang Chin; Robert L Baldwin; George I Makhatadze
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  Comparison of protein solution structures refined by molecular dynamics simulation in vacuum, with a generalized Born model, and with explicit water.

Authors:  Bin Xia; Vickie Tsui; David A Case; H Jane Dyson; Peter E Wright
Journal:  J Biomol NMR       Date:  2002-04       Impact factor: 2.835

Review 3.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

4.  Differential peptide expression in the central nervous system of the land snail Theba pisana, between active and aestivated.

Authors:  K J Adamson; T Wang; B A Rotgans; A V Kuballa; K B Storey; S F Cummins
Journal:  Peptides       Date:  2015-08-21       Impact factor: 3.750

5.  Structure-based prediction of binding affinities and molecular design of peptide ligands.

Authors:  I Luque; E Freire
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

6.  Inhibitor binding increases the mechanical stability of staphylococcal nuclease.

Authors:  Chien-Chung Wang; Tian-Yow Tsong; Yau-Heiu Hsu; Piotr E Marszalek
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

7.  The structural basis of peptide-protein binding strategies.

Authors:  Nir London; Dana Movshovitz-Attias; Ora Schueler-Furman
Journal:  Structure       Date:  2010-02-10       Impact factor: 5.006

8.  IL-10 signalling blockade at the time of immunization inhibits Human papillomavirus 16 E7 transformed TC-1 tumour cells growth in mice.

Authors:  Shu Chen; Xiongfei Wang; Xiaolian Wu; Ming Q Wei; Bin Zhang; Xiaosong Liu; Yuejian Wang
Journal:  Cell Immunol       Date:  2014-06-18       Impact factor: 4.868

9.  Validation and use of the MM-PBSA approach for drug discovery.

Authors:  Bernd Kuhn; Paul Gerber; Tanja Schulz-Gasch; Martin Stahl
Journal:  J Med Chem       Date:  2005-06-16       Impact factor: 7.446

View more
  5 in total

Review 1.  Genital warts treatment: Beyond imiquimod.

Authors:  Jianwei Yuan; Guoying Ni; Tianfang Wang; Kate Mounsey; Shelley Cavezza; Xuan Pan; Xiaosong Liu
Journal:  Hum Vaccin Immunother       Date:  2018-04-09       Impact factor: 3.452

Review 2.  Recent Developments and Applications of the MMPBSA Method.

Authors:  Changhao Wang; D'Artagnan Greene; Li Xiao; Ruxi Qi; Ray Luo
Journal:  Front Mol Biosci       Date:  2018-01-10

3.  Association of IL-10 and IL-10RA single nucleotide polymorphisms with the responsiveness to HBV vaccination in Chinese infants of HBsAg(+)/HBeAg(-) mothers: a nested case-control study.

Authors:  Simin Wen; Yanhua Wu; Yuchen Pan; Mengzhuo Cao; Dan Zhao; Chong Wang; Chuan Wang; Fei Kong; Jie Li; Junqi Niu; Jing Jiang
Journal:  BMJ Open       Date:  2018-11-28       Impact factor: 2.692

4.  Comparative proteomic study reveals the enhanced immune response with the blockade of interleukin 10 with anti-IL-10 and anti-IL-10 receptor antibodies in human U937 cells.

Authors:  Guoying Ni; Shu Chen; Jianwei Yuan; Shelley F Cavezza; Ming Q Wei; Hejie Li; Xuan Pan; Xiaosong Liu; Tianfang Wang
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

Review 5.  Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task.

Authors:  Guoying Ni; Lu Zhang; Xiaodan Yang; Hejie Li; Bowei Ma; Shelley Walton; Xiaolian Wu; Jianwei Yuan; Tianfang Wang; Xiaosong Liu
Journal:  Hum Vaccin Immunother       Date:  2020-03-11       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.